---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-065914"
form_type: "8-K"
ticker: "LONA"
cik: "0001620463"
company_name: "LeonaBio, Inc."
filed_at: "2024-05-29T23:59:59+00:00"
generated_at: "2026-06-01T07:41:35.930130+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Athira Pharma shareholders approve officer liability limitation charter amendment at 2024 annual meeting

## Summary
- Class I directors Kosacz, Litton, and Panzara elected with For votes ranging from 77% to 82% of votes cast (excl. broker non-votes).
- Ratification of Ernst & Young as auditor passed: 27,199,785 For, 59,069 Against, 99,855 Abstain.
- Amendment to certificate of incorporation limiting officer liability approved: 19,365,835 For, 602,307 Against, 347,812 Abstain.
- Broker non-votes were 7,042,755 on director election and charter amendment proposals.

## SEC filing metadata
- accession: 0000950170-24-065914
- form_type: 8-K
- ticker: LONA
- cik: 0001620463
- company_name: LeonaBio, Inc.
- filed_at: 2024-05-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1620463/000095017024065914/0000950170-24-065914-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1620463/000095017024065914/atha-20240523.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-065914
- JSON: https://secwatch.observer/filing/0000950170-24-065914.json
- Plain text: https://secwatch.observer/filing/0000950170-24-065914.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.